Navigation Links
Top cancer specialists receive ESMO awards
Date:9/15/2010

reast Unit, Lugano, Switzerland. Among other responsibilities, Dr Costa played a key role in the creation of the Italian School of Senology in 1984 and the European Institute of Oncology, also in Milan, in 1994. He has served as Secretary General of the European Organisation for Research and Treatment of Cancer (EORTC) and as a member of the European Commission's Europe Against Cancer programme. He is Editor-in-Chief of The Breast journal and a member of the editorial boards of various cancer publications and author of over 250 publications.

Dr Josep Tabernero, Chair of the ESMO Fellowship & Award Committee, comments that "Prof Costa is a leader in his field and has changed clinical standards, which made him the ideal choice for the ESMO Award."

The recipient of the 2010 Hamilton Fairley Award, Professor Bengt Glimelius, has focused his work on malignant lymphomas, gastrointestinal cancer, radiotherapy and psychosocial care. He has participated in several successful clinical trials, influencing today's standard of care. ESMO has recognized his achievements in all these areas by rewarding Prof Glimelius with the 2010 Hamilton Fairley Award which commemorates the founding fathers of medical oncology in Europe and is presented to candidates who are recognized for lifetime achievements in science and clinical/laboratory research. "His major scientific achievements lie within clinical research and in making a difference for patients through clinical studies" remarked Dr Tabernero.

Bengt Glimelius is professor in oncology at the Department of oncology, radiology and clinical immunology at the University of Uppsala and at the Department of oncology and pathology, Karolinska Institutet, Stockholm, Sweden. He is also responsible for the care of patients with gastrointestinal cancers at the University Hospital in Uppsala.

Prof Glimelius has been instrumental in the substantial improvements in locoregional control of rectal cancer through a
'/>"/>

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Molecule identified that increases survival of stomach cancer patients
2. Muscle wasting in cancer does not spare the heart
3. Biologists find way to reduce stem cell loss during cancer treatment
4. Connection between light at night and cancer revealed in additional study
5. Connection between light at night (LAN) and cancer revealed in additional study
6. New infrared light may open new frontier in fighting cancer, Tay Sachs
7. High-fat diet during puberty linked to breast cancer risk later in life
8. Researchers to activate anti-cancer gene
9. Researcher finds revolutionary way to treat eye cancer
10. Microneedle, quantum dot study opens door to new clinical cancer tools
11. LOreal Fellowship winner seeks to understand breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... DUBLIN , May 26, 2015 ... has announced the addition of the "Saudi ... report to their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... Saudi Arabia is projected to grow ... This high growth is attributed to the surging ...
(Date:5/22/2015)... 22, 2015 According to a ... (2D, 3D, Thermal, Emotion, Forensic), by Software (Middleware, Databases), by ... Utilities, Consumer and Home) - Global Forecast to 2020", ... $2.77 Billion in 2015 to $6.19 Billion by 2020, ... 79 market data Tables and   43 Figures spread ...
(Date:5/20/2015)... , May 20, 2015 /PRNewswire/ ... http://www.researchandmarkets.com/research/h8t4x6/5year ) has announced the addition ... the Global Iris Recognition Market"  report ... , ,This research service analyses trends ... the government and commercial sectors, globally. ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market Forecast and Opportunities, 2020 with Morpho Safran, ZK Technlogy, and Suprema Dominating 2Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2
... hundred years, cocoa has been the black gold of ... often darkened the pages of history. Now, a partnership ... farmers benefit from the cocoa trade., Mars Incorporated, in ... partners, will increase the production of cocoa for smallholder ...
... Pittsburgh, PAAn international team of researchers, including Carnegie ... resolved the evolutionary relationships of Necrolestes patagonensis ... to its burrowing and underground lifestyle. This much-debated ... paleontological riddle for more than 100 years. Scientific ...
... 19, 2012 Deciphering what causes the brain cell degeneration ... But a team led by scientists from The Scripps Research ... brain cells in a mouse model of Parkinson,s disease. The ... be useful in preventing the actual condition. The team, ...
Cached Biology News:Making chocolate an affordable luxury 2After 121 years, identification of 'grave robber' fossil solves a paleontological enigma 2After 121 years, identification of 'grave robber' fossil solves a paleontological enigma 3After 121 years, identification of 'grave robber' fossil solves a paleontological enigma 4After 121 years, identification of 'grave robber' fossil solves a paleontological enigma 5Scripps Research Institute team identifies a potential cause of Parkinson's disease 2Scripps Research Institute team identifies a potential cause of Parkinson's disease 3
(Date:5/29/2015)... (PRWEB) May 29, 2015 When ... Solutions with a request to design an ... moisture from prescription medications being produced using a ... that includes a robotic gantry, heat-saving windows, and ... dries trays of 3D-printed pills to exact specifications. ...
(Date:5/29/2015)... TRIANGLE PARK, N.C. , May 29, 2015 ... Roger Jeffs , Ph.D., President and Co-Chief Executive Officer ... the company,s business at the Jefferies 2015 Global Healthcare Conference ... The presentation and the immediately following Q&A session will take ... Time, and can be accessed via a live webcast on ...
(Date:5/28/2015)... May 28, 2015 ... the addition of Jain PharmaBiotech,s new report  ... Companies"  to their offering.       ... a challenge in management. With nearly 8 ... seven major markets of the world and ...
(Date:5/28/2015)... , May 27, 2015 ... the addition of Jain PharmaBiotech,s new report ... to their offering. An increasing ... biotechnology industries is anticipated. Nanotechnology will be ... - from formulations for optimal delivery to ...
Breaking Biology Technology:New industrial oven with “pill pushing” robotic gantry precisely removes excess moisture from 3D-printed pharmaceuticals 2Global Alzheimer Disease Report 2015-2024 - New Drugs, Markets and Companies 2Global Alzheimer Disease Report 2015-2024 - New Drugs, Markets and Companies 3Global Nanobiotechnology Market 2015-2024 - Applications, Markets and Companies 2Global Nanobiotechnology Market 2015-2024 - Applications, Markets and Companies 3
... , , DALLAS, Sept. 10 ... Board: ACCP), provided an update today on the Company,s clinical development plan for ... that has shown to be active in many solid tumor ... met with its partners Aosaikang Medicinal Group (ASK) in ...
... ROUGE, La., Sept. 10 Drug discovery and development ... enrollment and dosing of patients in a Phase 1 ... EP-100, the lead candidate from Esperance,s Cationic Lytic Peptide ... designed to seek and destroy cancer cells that over-express ...
... , INDIANAPOLIS, Sept. 10 Ener1 ... EnerDel, Inc. today named Richard L. Stanley as company President. Stanley ... experience and a distinguished record of creating new business lines. The ... EnerDel for continued success in the next phases of its commercial ...
Cached Biology Technology:Access Pharmaceuticals Provides Update on ProLindac(TM)Clinical Development Plan 2Access Pharmaceuticals Provides Update on ProLindac(TM)Clinical Development Plan 3Access Pharmaceuticals Provides Update on ProLindac(TM)Clinical Development Plan 4Esperance Pharmaceuticals Announces Initiation of Clinical Studies of its Novel Membrane-disrupting Agent, EP-100, in Patients with Cancer 2Esperance Pharmaceuticals Announces Initiation of Clinical Studies of its Novel Membrane-disrupting Agent, EP-100, in Patients with Cancer 3Lithium-Ion Battery Maker Names New President 2Lithium-Ion Battery Maker Names New President 3Lithium-Ion Battery Maker Names New President 4Lithium-Ion Battery Maker Names New President 5Lithium-Ion Battery Maker Names New President 6
Cell Culture Flask, 175 cm, tissue-culture treated polystyrene, barcoded...
... Microsphere/Microarray Stabilizer is an aqueous solution that ... non-toxic chemicals in a PBS buffer (phosphate ... This product contains a combination of 0.02% ... StabilCoat Plus Stabilizer provides optimum performance ...
... The Corning CellBIND surface is produced by ... more hydrophilic surface giving more consistent, even ... CellBIND enhances cell attachment and growth uunder ... medium. • CellBIND may provide a more ...
... Anti-PSD-95, clone K28/86.2, PDZ Domain ... Immunogen : GST fusion to residues ... 0.01M Tris pH 7.4, 0.075M NaCl ... routinely evaluated by immunoblot on rat ...
Biology Products: